| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |